Cargando…

PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway

INTRODUCTION: Progression and chemoresistance of acute myeloid leukemia (AML) contribute to most of the treatment failure. Notch pathway has been proven to be involved in many biological processes and diseases, especially AML. In this study, we aimed to explore genes correlated with Notch1 pathway i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qian, Li, Wei, Zhou, Ying, Jian, Jimo, Han, Shijie, Liu, Chao, Zhu, Xunxun, Ma, Daoxin, Ji, Min, Ji, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913764/ https://www.ncbi.nlm.nih.gov/pubmed/31849496 http://dx.doi.org/10.2147/OTT.S233234

Ejemplares similares

TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
por: Pang, Yihua, et al.
Publicado: (2020)

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
por: Li, Mingying, et al.
Publicado: (2022)

Deficiency of PRKD2 triggers hyperinsulinemia and metabolic disorders
por: Xiao, Yao, et al.
Publicado: (2018)

Notch1 is required for hypoxia-induced proliferation, invasion and chemoresistance of T-cell acute lymphoblastic leukemia cells
por: Zou, Jie, et al.
Publicado: (2013)

Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization
por: Liu, Jinting, et al.
Publicado: (2022)

The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
por: Döppler, Heike, et al.
Publicado: (2016)

Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
por: Zhang, Heng, et al.
Publicado: (2017)

Corrigendum to “Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization” [Redox Biol. 56 (2022) 102452]
por: Liu, Jinting, et al.
Publicado: (2022)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis
por: Borges, Sahra, et al.
Publicado: (2013)

miR‐4431 targets TRIP10/PRKD1 and impairs glucose metabolism
por: Pan, Chongge, et al.
Publicado: (2021)

Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation
por: Zang, Shaolei, et al.
Publicado: (2014)

Histologic Spectrum of Polymorphous Adenocarcinoma of the Salivary Gland Harbor Genetic Alterations Affecting PRKD Genes
por: Sebastiao, Ana Paula Martins, et al.
Publicado: (2019)

Novel Autosomal Recessive Splice-Altering Variant in PRKD1 Is Associated with Congenital Heart Disease
por: Massadeh, Salam, et al.
Publicado: (2021)

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022)

EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway
por: Yang, Xinyu, et al.
Publicado: (2023)

A zebrafish forward genetic screen identifies an indispensable threonine residue in the kinase domain of PRKD2
por: Giardoglou, Panagiota, et al.
Publicado: (2021)

Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
por: Hong, Chang-Sook, et al.
Publicado: (2021)

Super-enhancer-associated gene CAPG promotes AML progression
por: Ma, Qian, et al.
Publicado: (2023)

HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
por: Yan, Yuanyuan, et al.
Publicado: (2018)

Association of Dll4/Notch and HIF-1a -VEGF Signaling in the Angiogenesis of Missed Abortion
por: Fang, Yan, et al.
Publicado: (2013)

Rab5c promotes AMAP1–PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
por: Onodera, Yasuhito, et al.
Publicado: (2012)

Notch pathway activation targets AML-initiating cell homeostasis and differentiation
por: Lobry, Camille, et al.
Publicado: (2013)

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia
por: Zhou, Ying, et al.
Publicado: (2022)

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
por: HUANG, RUI, et al.
Publicado: (2015)

Deacetylation of YAP1 Promotes the Resistance to Chemo- and Targeted Therapy in FLT3-ITD(+) AML Cells
por: Feng, Panpan, et al.
Publicado: (2022)

Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML
por: Zhang, Yongping, et al.
Publicado: (2023)

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
por: Jian, Jimo, et al.
Publicado: (2023)

NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Zhong, Chaoqin, et al.
Publicado: (2021)

DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling
por: Yu, Shuang, et al.
Publicado: (2022)

SIRT3 deacetylase activity confers chemoresistance in AML via regulation of mitochondrial oxidative phosphorylation
por: Ma, Jiao, et al.
Publicado: (2019)

HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
por: Wang, Mei‐Qian, et al.
Publicado: (2023)

CD86 Is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes Its Progression
por: Zhang, Qianqian, et al.
Publicado: (2023)

Corrigendum: NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway
por: Zhong, Chaoqin, et al.
Publicado: (2021)

Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2021)

HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway
por: Han, Tao, et al.
Publicado: (2023)

Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
por: Zou, Qian, et al.
Publicado: (2022)

EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma
por: Yuan, Li, et al.
Publicado: (2022)

The emerging roles of Notch signaling in leukemia and stem cells
por: Liu, Na, et al.
Publicado: (2013)

The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer
por: Gao, Kun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8a5trlap298s28m4rpbc7asd9